Degroof Petercam Initiates the Coverage of Aelis Farma With a “Buy” Recommendation – Medical Marijuana Program Connection

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS) (Paris:AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announces the publication of an initiation report by Degroof Petercam, an independent Belgian-rooted investment bank. In the initiation report entitled “High on life”, published on April 24, 2023, Degroof Petercam initiates the coverage of the stock with a Buy recommen

Source link